Evidence map›Paper›PMID 21719706›Full record

ArticleThe Journal of biological chemistry2011

FTY720 (Gilenya) phosphate selectivity of sphingosine 1-phosphate receptor subtype 1 (S1P1) G protein-coupled receptor requires motifs in intracellular loop 1 and transmembrane domain 2.

William J Valentine, Virginia I Godwin, Daniel A Osborne, Jianxiong Liu, Yuko Fujiwara, James Van Brocklyn, Robert Bittman, Abby L Parrill, Gabor Tigyi

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. An update on sphingosine-1-phosphate receptor 1 modulators.Bioorganic & medicinal chemistry letters · 2018
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

William J ValentineDepartment of Physiology, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee 38163.
Virginia I GodwinDepartment of Chemistry, Computational Research on Materials Institute, University of Memphis, Memphis, Tennessee 38152.
Daniel A OsborneDepartment of Physiology, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee 38163.
Jianxiong LiuDepartment of Physiology, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee 38163.
Yuko FujiwaraDepartment of Physiology, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee 38163.
James Van BrocklynDepartment of Pathology, Ohio State University, Columbus, Ohio 43210.
Robert BittmanDepartment of Chemistry and Biochemistry, Queens College of The City University of New York, Flushing, New York 11367-1597.
Abby L ParrillDepartment of Chemistry, Computational Research on Materials Institute, University of Memphis, Memphis, Tennessee 38152.
Gabor TigyiDepartment of Physiology, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee 38163. Electronic address: gtigyi@uthsc.edu.

Funding

Ligand Recognition by Phospholipid Growth Factor ReceptorsR01CA092160 · NCI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI TIGYI, GABOR J · 2001 to 2022
$5.9M
Synthesis of Novel Bioactive Sphingolipids as a ResourceR24HL083187 · NHLBI · QUEENS COLLEGE · PI BITTMAN, ROBERT · 2006 to 2013
$2.5M
NCI NIH HHS CA-092160NCI NIH HHS R01 CA092160NHLBI NIH HHS HL-083187NHLBI NIH HHS R24 HL083187
6 · The paper itself

Abstract

FTY720 phosphate (FTY720P) is a high potency agonist for all the endothelial differentiation gene family sphingosine 1-phosphate (S1P) receptors except S1P receptor subtype 2 (S1P(2)). To map the distinguishing features of S1P(2) ligand recognition, we applied a computational modeling-guided mutagenesis strategy that was based on the high degree of sequence homology between S1P(1) and S1P(2). S1P(2) point mutants of the ligand-binding pocket were characterized. The head group-interacting residues Arg3.28, Glu3.29, and Lys7.34 were essential for activation. Mutation of residues Ala3.32, Leu3.36, Val5.41, Phe6.44, Trp6.48, Ser7.42, and Ser7.46, predicted to interact with the S1P hydrophobic tail, impaired activation by S1P. Replacing individual or multiple residues in the ligand-binding pocket of S1P(2) with S1P(1) sequence did not impart activation by FTY720P. Chimeric S1P(1)/S1P(2) receptors were generated and characterized for activation by S1P or FTY720P. The S1P(2) chimera with S1P(1) sequence from the N terminus to transmembrane domain 2 (TM2) was activated by FTY720P, and the S1P(2)(IC1-TM2)(S1P1) domain insertion chimera showed S1P(1)-like activation. Twelve residues in this domain, distributed in four motifs a-d, differ between S1P(1) and S1P(2). Insertion of (78)RPMYY in motif b alone or simultaneous swapping of five other residues in motifs c and d from S1P(1) into S1P(2) introduced FTY720P responsiveness. Molecular dynamics calculations indicate that FTY720P binding selectivity is a function of the entropic contribution to the binding free energy rather than enthalpic contributions and that preferred agonists retain substantial flexibility when bound. After exposure to FTY720P, the S1P(2)(IC1-TM2)(S1P1) receptor recycled to the plasma membrane, indicating that additional structural elements are required for the selective degradative trafficking of S1P(1).

Indexed as

Amino Acid MotifsAnimalsCarcinoma, HepatocellularCell Line, TumorFingolimod HydrochlorideHEK293 CellsHumansImmunosuppressive AgentsLigandsLipidsMutagenesisPropylene GlycolsProtein Structure, TertiaryRatsReceptors, G-Protein-CoupledReceptors, LysosphingolipidFingolimod HydrochlorideImmunosuppressive AgentsLigandsLipidsPropylene GlycolsReceptors, G-Protein-CoupledReceptors, LysosphingolipidRecombinant Fusion ProteinsSphingosine

Identifiers

PMID21719706
PMCPMC3162411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.